Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage.

about

Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson's Disease and Parkinsonism.

P2860

Q55023794-8EC36724-7021-4881-8713-B231ED2D4A53

P2860

Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage.

Item

http://www.wikidata.org/entity/Q49378467

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage.

@en

Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage.

@nl

type

Item

label

Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage.

@en

Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage.

@nl

prefLabel

Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage.

@en

Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage.

@nl

P1476

Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage.

@en

P2093

Aditi Shendre

http://www.w3.org/2001/XMLSchema#string

Chrisly Dillon

http://www.w3.org/2001/XMLSchema#string

Nita A Limdi

http://www.w3.org/2001/XMLSchema#string

Timothy Mark Beasley

http://www.w3.org/2001/XMLSchema#string

P2860

Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.

Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry.

Estimation of the warfarin dose with clinical and pharmacogenetic data.

Frailty in elderly people

Influence of regular physical activity on warfarin dose and risk of hemorrhagic complications.

A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.

Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis.

P304

588-596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.2089

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gaurav M Parmar

P577

2018-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29393514

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

6014885

http://www.w3.org/2001/XMLSchema#string

Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage.

about

P2860

P2860

Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932